Interview with Jeffrey Davis, CEO of Access Pharmaceuticals
OneMedPlace recently interviewed CEO Jeffrey Davis about the Dallas-based company’s pipeline.
Zogenix, Astellas Announce Positive Data for Unique Migraine Therapy
Zogenix, a pharmaceutical company specializing in the treatment of chronic pain, and Astellas Pharma have announced positive clinical trial data from two studies of their needle-free migraine treatment system.
Osteologix to Continue Development of Osteoporosis Drug
Osteologix is positioning NB S101 as an alternative to traditional osteoporosis treatments.
Positive Rheumatoid Arthritis Data for UCB, Trubion, Others
Data presented this weekend at the American College of Rheumatology’s annual meeting indicated that rheumatoid arthritis patients who adhered to a prescription drug regimen had better medical outcomes and lower medical costs.
BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle
BDSI focuses on the niche market of pain management and supportive cancer care.
DATATRAK: Low Valuation, Improving Results
DATATRAK International Inc. (OTC: DATA.PK) is a clinical trials information technology (IT) and services company that is focused on increasing its share of an estimated $720 million (M) Electronic Data Capture (EDC) market opportunity.
Onyx Pharmaceuticals to Acquire Proteolix
Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash.
Positive Phase II Data for Peregrine’s Lung Cancer Treatment
Peregrine Pharmaceuticals reported positive Phase II data in a clinical trial of bavituximab in patients with a deadly form of lung cancer.
Biotech News Out of Quebec
Medicago, a Canadian company focused on protein-based vaccines, has signed a contract with the U.S. Army to investigate ways to create biofuels from plants.
Two Pharma Companies to Offer Discounted Shares
Repros and Targacept have announced plans to offer shares in their respective companies at a reduced cost.